These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 18273573

  • 1. [Anticoagulation in atrial fibrillation].
    Binggeli C, Brunckhorst CB.
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [Abstract] [Full Text] [Related]

  • 2. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA.
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [Abstract] [Full Text] [Related]

  • 3. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM.
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract] [Full Text] [Related]

  • 4. The need for new oral anticoagulants in clinical practice.
    Hylek EM.
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [Abstract] [Full Text] [Related]

  • 5. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW.
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract] [Full Text] [Related]

  • 6. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H, Walter M, Walter C, Vetter S.
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [Abstract] [Full Text] [Related]

  • 7. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
    Lane DA, Lip GY.
    Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
    [No Abstract] [Full Text] [Related]

  • 8. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators.
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [Abstract] [Full Text] [Related]

  • 9. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H, Selçuk MT, Maden O.
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [Abstract] [Full Text] [Related]

  • 10. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ, Andreoli AM, Villani M, Capucci A.
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [Abstract] [Full Text] [Related]

  • 11. New oral anticoagulants in development.
    Weitz JI.
    Thromb Haemost; 2010 Jan; 103(1):62-70. PubMed ID: 20062934
    [Abstract] [Full Text] [Related]

  • 12. New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.
    Garcia DA, Lopes RD, Hylek EM.
    Thromb Haemost; 2010 Dec; 104(6):1099-105. PubMed ID: 20886196
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stroke prevention in atrial fibrillation patients.
    Marinigh R, Lip GY, Lane DA.
    Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589
    [Abstract] [Full Text] [Related]

  • 17. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project.
    Lip GY, Banerjee A, Lagrenade I, Lane DA, Taillandier S, Fauchier L.
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):941-8. PubMed ID: 22923275
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.